Cervical Cancer Screening Kit - Single Tube Formulation

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

Liquid-based cytology kit combined with HPV detection for cervical cancer screening. The system integrates morphological assessment with molecular HPV testing for comprehensive cervical dysplasia evaluation.

A diagnostic test kit for the detection of human papillomavirus (HPV) nucleic acids. The kit detects 18 types of HPV including 14 high-risk types recognized by the WHO that can lead to cervical cancer, as well as 4 medium-risk types identified by authoritative research as potentially related to cervical cancer. It uses hybridization capture and chemiluminescence methodology.

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

Comprehensive screening system for human papillomavirus detection and cervical cancer risk assessment. Integrates nucleic acid extraction, PCR instrumentation, and analysis workflows for clinical laboratory use.

A comprehensive system for HPV virus detection in cervical screening programs. The collection and preservation methodology ensures accurate identification of high-risk HPV strains for cancer prevention.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

Real-time PCR assay for high-risk HPV detection and screening. Supports cervical cancer prevention through HPV risk assessment.

Molecular diagnostic test for detection and genotyping of human papillomavirus. Supports cervical cancer screening and HPV-related disease diagnosis.

Integrated system for HPV detection and cervical cancer screening utilizing nucleic acid extraction and PCR-based analysis. Provides accurate identification of high-risk HPV strains to enable early cervical cancer detection and prevention.

A comprehensive nucleic acid detection kit capable of identifying 28 different types of human papillomavirus (HPV). This diagnostic test provides broad HPV coverage including both high-risk and low-risk types for comprehensive cervical cancer screening. The kit is designed for clinical laboratory and cervical cancer prevention programs.